INEGY better than Crestor™ in Achieving Multiple “Goals” for LDL-Cholesterol & Other CHD Risk Factors in Hypercholesterolemia Patients

June 13th, 2007 | Category: Cholesterol

INEGY™ (ezetimibe/simvastatin) allowed significantly more patients with hypercholesterolemia than Crestor™(rosuvastatin) to achieve study specified levels (”Goals”) for both Low Density Lipoprotein (”bad”) cholesterol (LDL-C) and each one of the following coronary heart disease

(CHD) risk factors: C-reactive protein (CRP), Apolipoprotein B (Apo B) or Non-HDL-cholesterol (non-HDL-C). [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • INEGY Better Than Lipitor™ In Achieving Recommended Levels Of LDL-Cholesterol In Diabetes 2 Patients With Hypercholesterolemia
  • UK GP Success In Fight Against Cholesterol
  • 15 Month Old Kids Should Have Cholesterol Test
  • Published Study Reveals Next Pharmaceuticals’ Flavoxineâ„¢ Reduces Multiple Heart Health Risk Factors Including High Cholesterol
  • Merck/Schering-Plough Pharmaceuticals Comments On Results Of The ENHANCE Study

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.